Frontiers | WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
e-Oftalmo
Repurposing anticancer drugs for the management of COVID-19 - ScienceDirect
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? | Journal of Translational Medicine | Full Text
Frontiers | Voltage-Gated Potassium Channels as Regulators of Cell Death
Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy. - Abstract - Europe PMC
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? - The Lancet Respiratory Medicine
Diagnóstico ecográfico de los tumores vasoproliferativos del fondo de ojo
CircRNA–miRNA networks in regulating bone disease - Huang - 2022 - Journal of Cellular Physiology - Wiley Online Library
Cancers | Free Full-Text | Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors | HTML
PDF) New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis
Frontiers | Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
JCM | Free Full-Text | Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence | HTML
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
Standardised B-scan and A-scan echographic evaluation of spontaneous anterior uveal melanomas in the dog - ScienceDirect
Ultrassom demonstrando o ângulo kappa. | Download Scientific Diagram
Cells | Free Full-Text | Fibroblast Growth Factor Receptor Signaling in Skin Cancers | HTML
Rho GTPase signaling in cancer progression and dissemination | Physiological Reviews
Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy | Bioconjugate Chemistry
Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy | SpringerLink
HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors
